VRNA NASDAQ
Verona Pharma plc
1W: +0.3%
1M: +0.6%
3M: +23.1%
1Y: +272.4%
3Y: +1033.7%
5Y: +1517.4%
$106.91
Last traded 2025-10-06 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$122M
-143.3% ▼
Capital Expenditures
$580K
-14265130.0% ▼
5Y CAGR: +9.4%
Free Cash Flow
-$123M
-144.5% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$128M
+191.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$65M | -$56M | -$69M | -$55M | -$173M |
| Depreciation & Amort. | $623K | $629K | $636K | $116K | $1M |
| Stock-Based Comp. | $22M | $25M | $14M | $19M | $41M |
| Change in Working Capital | -$2M | $13M | -$11M | -$14M | -$6M |
| Other Non-Cash Items | $18K | $239K | $5M | -$332K | $15M |
| Operating Cash Flow | -$45M | -$33M | -$60M | -$50M | -$122M |
| — Investing Activities — | |||||
| Capital Expenditures | -$82K | -$12K | -$29K | $0 | -$580K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $10M | $0 | $0 | $0 | $0 |
| Other Investing | $7M | -$12K | -$29K | $0 | $0 |
| Investing Cash Flow | $10M | -$12K | -$29K | $0 | -$580K |
| — Financing Activities — | |||||
| Net Debt Issuance | $5M | $0 | $5M | $39M | $70M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$13M | -$7M | -$14M | -$3M | $83M |
| Financing Cash Flow | $192M | -$6M | $141M | $93M | $251M |
| Net Change in Cash | $158M | -$40M | $79M | $44M | $128M |
| Cash End of Period | $188M | $148M | $228M | $272M | $400M |
| Free Cash Flow | -$45M | -$33M | -$60M | -$50M | -$123M |